Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors

Using electronic health records to predict costs and outcomes in stable coronary artery disease

(2016) Miqdad Asaria et al.   HEART

Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model

(2016) Gary S. Collins et al.   STATISTICS IN MEDICINE

Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations

(2016) A Timmis et al.   BMJ-British Medical Journal

Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations

(2016) A Timmis et al.   BMJ-British Medical Journal

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

(2015) Pallav Garg et al.   AMERICAN HEART JOURNAL

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement

(2015) G. S. Collins et al.   CIRCULATION

How Does Cardiovascular Disease First Present in Women and Men?CLINICAL PERSPECTIVES

(2015) Julie George et al.   CIRCULATION

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective

(2015) Tomas Jernberg et al.   EUROPEAN HEART JOURNAL

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

(2015) Emily Herrett et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation

(2015) Line Melgaard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Balancing the Risks and Benefits of Dual Platelet Inhibition

(2015) John F. Keaney   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

(2015) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people

(2015) Anoop Dinesh Shah et al.   Lancet Diabetes & Endocrinology

mice: Multivariate Imputation by Chained Equations inR

(2015) Stef van Buuren et al.   Journal of Statistical Software

Individualizing treatment choices using quantitative methods

(2014) Stuart J. Pocock et al.   AMERICAN HEART JOURNAL

Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial

(2014) Marc P. Bonaca et al.   AMERICAN HEART JOURNAL

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction

(2014) Mar Pujades-Rodriguez et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

(2014) Eleni Rapsomaniki et al.   LANCET

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

(2014) Laura Mauri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention

(2014) Mar Pujades-Rodriguez et al.   PLoS One

Defining Disease Phenotypes Using National Linked Electronic Health Records: A Case Study of Atrial Fibrillation

(2014) Katherine I. Morley et al.   PLoS One

External validation of a Cox prognostic model: principles and methods

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients

(2013) Eleni Rapsomaniki et al.   EUROPEAN HEART JOURNAL

Completeness and usability of ethnicity data in UK-based primary care and hospital databases

(2013) Rohini Mathur et al.   JOURNAL OF PUBLIC HEALTH

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study

(2013) E. Herrett et al.   BMJ-British Medical Journal

Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

(2013) Ewout W. Steyerberg et al.   PLOS MEDICINE

Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome

(2012) Adam C. Salisbury et al.  

Risk prediction models: II. External validation, model updating, and impact assessment

(2012) Karel G M Moons et al.   HEART

Data Resource Profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)

(2012) S. C. Denaxas et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Association Between Admission Supine Systolic Blood Pressure and 1-Year Mortality in Patients Admitted to the Intensive Care Unit for Acute Chest Pain

(2010) Ulf Stenestrand   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications

(2009) Stuart J. Pocock et al.   CIRCULATION